Associate Professor Ruth Colagiuri, founder of the Juvenile Arthritis Foundation Australia, whose grandchild lives with arthritis, told BioPharmaDispatch that the announcement was excellent news for the community because it an important treatment option affordable for more families.
'Juvenile arthritis is one of the most under-recognised, misunderstood, and neglected childhood
December 11, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Nurse prescribing reform set to expand access to PBS subsidised medicines
July 3, 2026 - - Latest News -
Cartherics emerges as Asia Pacific leader in off-the-shelf immune cell therapy
July 2, 2026 - - Australian Biotech -
Minister looks to be sending a very clear message about these therapies and the PBS
July 2, 2026 - - Latest News -
The end-game of strong-arming companies over prices at the expense of patients and process
July 2, 2026 - - Latest News -
Commercial outsourcing emerges as a strategic option to patient access
July 1, 2026 - - Latest News -
The minister is following a tried and tested process, but what is the risk in this new world?
July 1, 2026 - - Latest News -
Patient alarm over the potential loss of subsidised access to MS medicines
July 1, 2026 - - Latest News


